Nanoparticle can target, kill cancer cells simultaneously

12/16/2009 | CNET

Researchers have developed a nanoparticle that can target and kill cancer cells in one process and be monitored in real time through MRI. While human clinical trials of the nanoparticle could still be years away, the researchers hope patients eventually can be injected with a combination of these nanoparticles and antibodies that can target and eliminate specific cancer cells.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC
Chief, Product Review Branch
FDA/Center for Biologics Evaluation and Research
Silver Spring, MD
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ